Access to drugs for treatment of noncommunicable diseases.
Main Author: | Thomas J Bollyky |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2013-01-01
|
Series: | PLoS Medicine |
Online Access: | http://europepmc.org/articles/PMC3720246?pdf=render |
Similar Items
-
Global susceptibility and response to noncommunicable diseases
by: Allen, L, et al.
Published: (2018) -
Noncommunicable diseases, access to essential medicines and universal health coverage
by: David Beran, et al.
Published: (2019-01-01) -
Noncommunicable diseases and noncommunicable eye diseases: What is the way forward?
by: Meena Chakrabarti
Published: (2020-01-01) -
Noncommunicable disease research
by: Luke Allen
Published: (2016-01-01) -
Microbiota-accessible carbohydrates (MACs) as novel gut microbiome modulators in noncommunicable diseases
by: Gamze Ayakdaş, et al.
Published: (2023-09-01)